We have not verified a BAA statement from ClinicalTrials.gov API v2
The vendor's own published pages do not state whether it signs a Business Associate Agreement. Unverified items are shown as Unknown on this profile, never guessed. Confirm with the vendor before using this product with protected health information.
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Accepts healthy volunteers A type of eligibility criteria that indicates whether people who do not have the condition/disease being studied can participate in that clinical study. Active comparator arm An arm type in which a group of participants receives an intervention/treatment considered to be effective (or active) by health care providers. Adverse event An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of time after the study has ended. This change may or may not be caused by the intervention/treatment being studied. Age or age group
A type of eligibility criteria that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups: The age groups are:
Child (birth-17) Adult (18-64) Older Adult (65+)
All-cause mortality A measure of all deaths, due to any cause, that occur during a clinical study. Allocation A method used to assign participants to an arm of a clinical study. The types of allocation are randomized allocation and nonrandomized. Arm A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol. Arm type A general description of the clinical trial arm. It identifies the role of the intervention that participants receive. Types of arms include experimental arm, active comparator arm, placebo comparator arm, sham comparator arm, and no intervention arm. Baseline characteristics Data collected at the beginning of a clinical study for all participants and for each arm or comparison group. These data include demographics, such as age, sex/gender, race and ethnicity, and study-specific measures (for example, systolic blood pressure, prior antidepressant treatment). Canceled submission Indicates that the study sponsor or investigator recalled a submission of study results before quality control (QC) review took place. If the submission was canceled on or after May 8, 2018, the date is shown. After submission of study results, a study record cannot be modified until QC review is completed, unless the submission is canceled. Certain agreements Information required by the Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801). In general, this is a description of any agreement between the sponsor of a clinical study and the principal investigator (PI) that does not allow the PI to discuss the results of the study or publish the study results in a scientific or academic journal after the study is completed. Certification A sponsor or investigator may submit a certification to dela
Contact vendor for pricing
Share your experience to help healthcare professionals make better decisions.
+2 more